Is Ketamine Legal in Colorado?

Legal is the floor. It is not the standard.

It is almost always eleven at night when a woman types this into her phone.

She has read about ketamine for a year. She has a friend who did it. She is not going to ask her doctor about it at a fifteen-minute appointment, and she is not going to ask her sister. So she asks Google, quietly, in the dark.

Here is the plain answer, and then the parts that actually matter.

The short version

Yes. Ketamine is legal in Colorado with a prescription from a licensed provider. There is no special Colorado law that bans it and no special Colorado law that makes it easier. It is a prescription medicine here the same way it is a prescription medicine in every other state.

That is the whole legal answer. The rest of this post is about what the legal answer does not tell you, because "legal" and "safe" and "well run" are three different questions, and only one of them has a one-word answer.

What ketamine actually is, legally

Ketamine has been an FDA-approved anesthetic since 1970. It is a Schedule III controlled substance, which puts it in the same legal tier as testosterone and codeine-containing cough syrup: real oversight, real prescribing rules, not a felony to possess with a prescription.

When a provider prescribes it for anxiety, depression or a stuck pattern, that is an off-label use. Off-label prescribing is legal and common across medicine. It also means something specific that is worth saying out loud: the FDA has not approved ketamine for the treatment of any psychiatric disorder, and has not established a safe and effective dose for one.

The one exception is Spravato, an esketamine nasal spray approved for treatment-resistant depression. It comes with strict rules: it is given in a certified health care setting and the patient is monitored for two hours afterward. That monitoring requirement is not bureaucracy. It is the FDA saying, in the plainest way it knows how, that someone should be watching.

The part that matters more than legality

Most of what is available right now is compounded ketamine — usually a lozenge or a sublingual troche — prescribed after a telehealth evaluation and taken at home.

In October 2023 the FDA issued a warning about exactly this: compounded oral and sublingual ketamine marketed through telemedicine platforms for psychiatric use. The risks named were abuse and misuse, psychiatric events, raised blood pressure, respiratory depression and bladder problems. The agency's central concern was not the molecule. It was the absence of anyone in the room. Without monitoring, nobody sees the sedation. Nobody sees the dissociation. The FDA cited a patient who developed dangerous respiratory depression at home with blood levels roughly double what is used in anesthesia.

Legal is the floor, not the standard. The real question is not whether you are allowed to do this. It is who is with you while you do.

There is also a deadline on the calendar

The reason a doctor can prescribe you a controlled medicine without ever seeing you in person is a temporary federal rule, extended four times now since the pandemic. The current extension runs from January 1 through December 31, 2026. Permanent rules are still being written.

Nobody knows exactly what happens in January. It may be extended again. It may be replaced with something that requires an in-person visit first. If you have been thinking about this for a year, that is worth knowing — not as a reason to rush, but as a reason not to assume the door stays open on its own.

Psilocybin is a completely different law

Women searching for ketamine in Colorado usually end up reading about mushrooms too, so here is the distinction, because people conflate them constantly.

Colorado's Natural Medicine Health Act created a licensed system for psilocybin. Adults 21 and older can take part through a licensed facilitator at a licensed healing center. The first healing center license went to a Denver center in March 2025, and centers have opened since, including three in Boulder. The medicine stays on site and is taken under supervision. There are no retail shops. Adults can grow mushrooms at home and give them to other adults, but selling them is still illegal.

Two practical differences: ketamine runs through a prescriber, psilocybin runs through a license. And the money is different. Boulder's licensed centers were charging roughly $1,500 to $3,400 for a session when they opened, and insurance does not cover any of it.

What to ask before you hand anyone your credit card

• Who is the prescriber, and are they licensed in Colorado?
• Is there a real medical evaluation before the first dose, or just a form?
• Is anyone with me while I am under? Who, and for how long?
• Does anyone know where I physically am that day, and who to call?
• What happens afterward — is there any structure for the week after, or does it end when the dose wears off?
• What am I paying, in total, including the medical piece?

A good provider will not be annoyed by any of these. If the answers are vague, that is your answer.

How we do it

RESET is built around the gap the FDA warning points at. A physician evaluates you before anything else happens, and that evaluation is separate from the program. Ceremonies happen live, at home, with a small group on Zoom and a facilitator present the entire time. Before every ceremony, each woman sends the physical address where she will be and an emergency contact, so help can be directed to her door if it is ever needed. Afterward there is practice, because what the medicine opens is not the same thing as what you build.

In Colorado, RESET is $397 a month, plus a one-time $300 medical evaluation paid directly to the physician.

Wondering whether this is for you? Five questions, five minutes, no call required.

Is RESET right for me?

This post is about the law, not your health. It is not medical advice, and nothing here is a promise about what any medicine will do for you. Questions about your own body and your own medications belong with a medical provider. Last reviewed September 2026 — the federal telehealth rule described here expires December 31, 2026.